Nyxoah S.A. (NYXH) Key Metrics
NYXH key metrics, 2017–2025
Fiscal year ended December 31, 2025 · eurosNYXH returns How much profit the business earns on the capital it uses.
NYXH financial health Debt, liquidity and how easily interest is covered.
NYXH efficiency & capital use Working capital cycle and where the cash goes.
NYXH returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
NYXH debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
NYXH key metrics in euros
2017–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Returns & profitability | |||||||||
| Return on equity (ROE) | −111.0% | −56.1% | −39.6% | −23.2% | −20.6% | −20.1% | −129.0% | −121.2% | −229.1% |
| Return on invested capital (ROIC) | −140.1% | −89.9% | −78.9% | −82.6% | −92.4% | −68.6% | −259.1% | — | — |
| Return on assets (ROA) | −65.1% | −41.9% | −32.0% | −19.7% | −17.8% | −15.6% | −48.3% | −62.3% | −93.1% |
| Return on tangible assets | −131.8% | −54.8% | −55.7% | −29.4% | −19.0% | −10.2% | −79.6% | −50.5% | −93.1% |
| Free cash flow margin | −681.6% | — | — | — | — | — | — | — | — |
| Financial health | |||||||||
| Total debt | €42.1M | €22.7M | €12.7M | €11.9M | €11.7M | €14.1M | €9.7M | €5.8M | €5.3M |
| Cash & short-term investments | €48.0M | €85.6M | €57.7M | €94.9M | €135.5M | €112.9M | €6.6M | €16.8M | €10.1M |
| Net debt | −€5.9M | −€62.9M | −€45.0M | −€83.0M | −€123.8M | −€98.8M | €3.1M | −€11.0M | −€4.8M |
| Debt / equity | 0.86 | 0.20 | 0.13 | 0.10 | 0.08 | 0.12 | 3.64 | 0.56 | 1.16 |
| Debt / assets | 0.36 | 0.14 | 0.10 | 0.08 | 0.07 | 0.10 | 0.57 | 0.32 | 0.47 |
| Current ratio | 1.25 | 4.56 | 4.73 | 6.72 | 12.10 | 14.70 | 1.82 | 8.77 | 6.11 |
| Quick ratio | 1.16 | 4.34 | 4.50 | 6.66 | 12.07 | 14.69 | 1.82 | 9.14 | 6.44 |
| Interest coverage | -49.0 | -30.9 | -37.4 | -137.1 | -68.0 | -56.7 | -12.1 | -291.4 | -274.1 |
| Working capital | €12.3M | €76.6M | €53.9M | €85.3M | €128.5M | €107.3M | €4.0M | €15.5M | €8.9M |
| Invested capital | €43.2M | €50.4M | €53.0M | €37.4M | €24.8M | €20.1M | €5.7M | −€536,000 | −€314,000 |
| Tangible asset value | −€1.0M | €62.9M | €51.4M | €80.4M | €123.3M | €99.5M | −€3.8M | €10.5M | €4.5M |
| Net current asset value | −€8.2M | €52.9M | €42.2M | €74.5M | €117.9M | €94.5M | −€5.5M | €10.0M | €4.1M |
| Capital allocation | |||||||||
| Dividends paid | €0 | €0 | €0 | €0 | €0 | €0 | — | — | — |
| Capex / revenue | 8.0% | 134.3% | 252.1% | 530.1% | 1,387.0% | 15,478.3% | — | — | — |
| Capex / depreciation | 0.18 | 2.23 | 4.64 | 8.46 | 7.11 | 17.23 | 13.36 | 0.81 | 1.05 |
| Stock-based compensation / revenue | 48.8% | 87.8% | 60.1% | 87.5% | 149.1% | 3,694.2% | — | — | — |
| R&D / revenue | 427.4% | 759.2% | 636.1% | 514.3% | 698.6% | 4,217.4% | — | — | — |
| SG&A / revenue | 463.4% | 629.5% | 474.8% | 611.4% | 1,304.3% | 16,442.0% | — | — | — |
| Efficiency | |||||||||
| Days sales outstanding | 252.8 | 475.8 | 329.8 | 280.7 | 968.9 | 11,578.8 | — | — | — |
| Days of inventory on hand | 463.1 | 944.4 | 462.5 | 194.9 | 248.9 | 818.8 | — | -2,508.8 | -2,351.4 |
| Days payables outstanding | 863.1 | 923.2 | 658.5 | 677.2 | 2,318.9 | 18,315.0 | 811.3 | 1,909.9 | 1,590.8 |
| Cash conversion cycle (days) | -147.2 | 497.0 | 133.9 | -201.6 | -1,101.0 | -5,917.4 | — | — | — |
| Receivables turnover | 1.44 | 0.77 | 1.11 | 1.30 | 0.38 | 0.03 | 0.00 | 0.00 | 0.00 |
| Payables turnover | 0.42 | 0.40 | 0.55 | 0.54 | 0.16 | 0.02 | 0.45 | 0.19 | 0.23 |
| Inventory turnover | 0.79 | 0.39 | 0.79 | 1.87 | 1.47 | 0.45 | — | — | — |
| Asset turnover | 0.07 | 0.03 | 0.03 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | €6.9M | €5.9M | €3.9M | €2.4M | €2.3M | €2.2M | €1.5M | €389,000 | €46,000 |
| Average payables | €8.7M | €3.9M | €3.0M | €2.1M | €1.9M | €1.5M | €1.1M | €497,500 | €389,000 |
| Average inventory | €4.7M | €4.0M | €2.1M | €614,000 | €206,648 | €67,295 | — | −€653,500 | −€575,000 |
| Intangibles / total assets | 42.3% | 31.8% | 37.5% | 27.4% | 14.8% | 13.9% | 37.7% | 0.0% | 0.0% |
Computed from NYXH's annual financial statements (latest annual report filed March 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in euros; data from EODHD. Averages use the opening and closing balance of each year.
NYXH valuation and financial ratios
Nyxoah earned a return on equity of −111.0% and a return on invested capital of −140.1% in fiscal 2025. It ended the year with €42.1 million of debt and €48.0 million in cash and short-term investments, a net cash position of €5.9 million.
See the NYXH income statement, the NYXH chart for price history, or the NYXH stock overview for the latest quote and news.
NYXH key metrics FAQ
What is Nyxoah's return on equity?
Nyxoah's return on equity (ROE) was −111.0% in fiscal 2025: net income of -€90.1 million on average shareholders' equity of €81.2 million.
What is Nyxoah's ROIC?
Nyxoah's return on invested capital was −140.1% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Nyxoah have?
Nyxoah had total debt of €42.1 million at the end of fiscal 2025, a debt-to-equity ratio of 0.86 and more cash than debt.
Does Nyxoah pay a dividend?
Nyxoah did not pay a dividend in fiscal 2025.
What is Nyxoah's current ratio?
Nyxoah's current ratio was 1.25 at the end of fiscal 2025: current assets were 1.25 times current liabilities.